Betahistine belongs to a group of medications used to treat vertigo associated with Ménière's disease. Vertigo is a condition that causes sufferers to have a sensation of rotation or movement of themselves or their surroundings.

Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms. It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it. [4] [5]

Jan 7, 2025 · Serc - Mesilate dilates precapiilary sphincters, increasing the blood flow in the inner ear. It controls the permeability of capillaries in the inner ear, thereby removes endolymphatic hydrops. It also improves cerebral circulation, increasing blood flow in the internal carotid artery.

Aug 8, 2024 · This drug (brand name Serc, chemical name betahistine), is advocated as a vestibular suppressant mainly for Meniere's disease.

As Canada's trusted pharmacy, Rexall provides detailed drug factsheets for Serc with common uses, dosage instructions, side effects & drug interactions.

Serc contains betahistine. This medicine is called a histamine analogue. It is used to treat: hearing loss suffered by people with Ménière's disease This medicine works by improving blood flow in the inner ear. This lowers the build up of pressure. 2. Before you take Serc Do not take Serc if:

SERC ® is used for reducing the episodes of recurrent vertigo (dizziness) associated with Ménière’s disease. What it does SERC ® is a type of medicine called a histamine-analogue.

side effects associated with betahistine dihydrochloride are not related to gastric acid production, Serc is contraindicated in the presence of peptic ulcer and in patients with a history of this condition. Serc is also contraindicated in patients with pheochromocytoma. patients. Serc is not recommended for use in children.

Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 …

Sep 10, 2017 · SERC contains the active ingredient betahistine dihydrochloride. SERC is used to treat a disorder of your inner ear. This disorder may include one or more of the following symptoms, in one or both ears: ringing in the ears (tinnitus), loss of clear hearing and problems with balance (vertigo).